Delivery Order SPE2DB22D9765-SPE2DB25FH0FW

Award Date 10/25/24
Potential Completion Date 11/18/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,094.80, is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth up to $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes, with a period of performance through April 18, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number SPE2DB, valued at up to $4,999,999 through the end of 2025, which allows DLA to issue firm fixed-price...
This federal contract award is for the delivery of Xolair 150 mg/mL syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $2,321.10, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the delivery of Xolair 150 mg/ml syringes. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $21,663.60, is for the delivery of Xolair 150 mg/ml syringes and has an ultimate completion date of July 17, 2024. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the...
This federal contract award is for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,547.40 and an ultimate completion date of March 31, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award is for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $6,189.60 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award is for the delivery of Xolair 150 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price delivery order was issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA. This IDC enables the DLA to issue delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite-delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,737 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 75 mg/0.5 ml syringe 0.5 ml, with an ultimate completion date of October 30, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group Inc. under the DLA's...
  • SPE2DB22D9765
    Indefinite Delivery Contract
  • SPE2DB22D9765-SPE2DB25FH0FW
    Delivery Order

The federal contract award is for the delivery of Xolair 150 mg/mL syringes to the Defense Logistics Agency (DLA). The $3,094.80 firm fixed-price delivery order was awarded on October 25, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of November 18, 2024.

This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/24/25, 9:02 AM